Zoetis Inc. Lease, Cost
Zoetis Inc. (ZTS) reported Lease, Cost of $111.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-02-12
- Zoetis Inc. lease, cost for fiscal 2025 was $111.00M, a 21.98% increase from fiscal 2024.
- Zoetis Inc. lease, cost for fiscal 2024 was $91.00M, a 3.41% increase from fiscal 2023.
- Zoetis Inc. lease, cost for fiscal 2023 was $88.00M, a 17.33% increase from fiscal 2022.
- Zoetis Inc. lease, cost for fiscal 2022 was $75.00M, a 3.85% decline from fiscal 2021.
| Period end | Lease, Cost 12 month |
|---|---|
| 2025-12-31 | $111.00M 10-K · filed 2026-02-12 |
| 2024-12-31 | $91.00M 10-K · filed 2026-02-12 |
| 2023-12-31 | $88.00M 10-K · filed 2026-02-12 |
| 2022-12-31 | $75.00M 10-K · filed 2025-02-13 |
| 2021-12-31 | $78.00M 10-K · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |